These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3275899)

  • 1. Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1988 Jan; 318(4):262-4. PubMed ID: 3275899
    [No Abstract]   [Full Text] [Related]  

  • 2. Final report on the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in the early termination of the aspirin component of the Physicians' Health Study. Data Monitoring Board of the Physicians' Health Study.
    Cairns J; Cohen L; Colton T; DeMets DL; Deykin D; Friedman L; Greenwald P; Hutchison GB; Rosner B
    Ann Epidemiol; 1991 Aug; 1(5):395-405. PubMed ID: 1669520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.
    Manson JE; Buring JE; Satterfield S; Hennekens CH
    Am J Prev Med; 1991; 7(3):150-4. PubMed ID: 1931143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction.
    Young FE; Nightingale SL; Temple RA
    JAMA; 1988 Jun; 259(21):3158-60. PubMed ID: 3367492
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical markers of compliance in the Physicians' Health Study.
    Satterfield S; Greco PJ; Goldhaber SZ; Stampfer MJ; Swartz SL; Stein EA; Kaplan L; Hennekens CH
    Am J Prev Med; 1990; 6(5):290-4. PubMed ID: 2268456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of aspirin and beta-carotene among U.S. physicians.
    Hennekens CH; Eberlein K
    Prev Med; 1985 Mar; 14(2):165-8. PubMed ID: 3900975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
    Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
    Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and the prevention of stroke after transient ischaemic attack.
    Warlow C
    Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126
    [No Abstract]   [Full Text] [Related]  

  • 10. Migraine and subsequent risk of stroke in the Physicians' Health Study.
    Buring JE; Hebert P; Romero J; Kittross A; Cook N; Manson J; Peto R; Hennekens C
    Arch Neurol; 1995 Feb; 52(2):129-34. PubMed ID: 7848119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can aspirin prevent recurrence of heart attacks and strokes?
    Kent S
    Geriatrics; 1982 Jan; 37(1):169-72. PubMed ID: 7033047
    [No Abstract]   [Full Text] [Related]  

  • 12. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians.
    Stampfer MJ; Buring JE; Willett W; Rosner B; Eberlein K; Hennekens CH
    Stat Med; 1985; 4(2):111-6. PubMed ID: 4023472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.
    Glynn RJ; Buring JE; Manson JE; LaMotte F; Hennekens CH
    Arch Intern Med; 1994 Dec 12-26; 154(23):2649-57. PubMed ID: 7993148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
    Lubsen J
    Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and cardiovascular disease.
    Hennekens CH; Buring JE
    Bull N Y Acad Med; 1989 Jan; 65(1):57-68. PubMed ID: 2690995
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost and efficiency in clinical trials: the U.S. Physicians' Health Study.
    Buring JE; Hennekens CH
    Stat Med; 1990; 9(1-2):29-33. PubMed ID: 2345836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual request to a willing study population.
    González ER
    Arch Intern Med; 1981 Feb; 141(2):159. PubMed ID: 7458509
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
    Hennekens CH; Buring JE; Manson JE; Stampfer M; Rosner B; Cook NR; Belanger C; LaMotte F; Gaziano JM; Ridker PM; Willett W; Peto R
    N Engl J Med; 1996 May; 334(18):1145-9. PubMed ID: 8602179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
    Christen WG; Glynn RJ; Ajani UA; Schaumberg DA; Chew EY; Buring JE; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Aug; 119(8):1143-9. PubMed ID: 11483080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and myocardial infarction.
    Drug Ther Bull; 1987 Mar; 25(5):17-9. PubMed ID: 3545741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.